Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
SVA [NASD]
Sinovac Biotech Ltd.
Index- P/E54.40 EPS (ttm)0.10 Insider Own9.90% Shs Outstand55.57M Perf Week1.30%
Market Cap302.30M Forward P/E60.44 EPS next Y0.09 Insider Trans- Shs Float45.91M Perf Month15.01%
Income5.90M PEG4.53 EPS next Q-0.01 Inst Own47.00% Short Float3.47% Perf Quarter-2.33%
Sales70.70M P/S4.28 EPS this Y148.10% Inst Trans-0.13% Short Ratio8.15 Perf Half Y-6.69%
Book/sh2.24 P/B2.43 EPS next Y325.00% ROA2.60% Target Price9.50 Perf Year-3.03%
Cash/sh1.61 P/C3.37 EPS next 5Y12.00% ROE4.80% 52W Range4.51 - 8.14 Perf YTD-11.11%
Dividend- P/FCF- EPS past 5Y-7.30% ROI6.00% 52W High-35.01% Beta0.41
Dividend %- Quick Ratio2.00 Sales past 5Y9.30% Gross Margin70.70% 52W Low17.29% ATR0.22
Employees715 Current Ratio2.30 Sales Q/Q-30.90% Oper. Margin9.30% RSI (14)54.12 Volatility2.68% 5.17%
OptionableYes Debt/Eq0.38 EPS Q/Q-300.00% Profit Margin8.50% Rel Volume0.44 Prev Close5.44
ShortableYes LT Debt/Eq0.09 EarningsNov 17 Payout0.00% Avg Volume195.12K Price5.29
Recom2.00 SMA201.21% SMA503.45% SMA200-10.42% Volume85,837 Change-2.76%
15-Aug-14Reiterated Aegis Capital Buy $7 → $10
15-Aug-13Upgrade Aegis Capital Hold → Buy $7
12-Dec-12Initiated Aegis Capital Hold $2.50
07-Jan-11Reiterated Brean Murray Buy $5.50 → $4.80
04-Jan-11Downgrade WBB Securities Buy → Speculative Buy $7.50 → $7.50
11-Nov-10Upgrade Brean Murray Hold → Buy $5.50
20-Apr-10Initiated WBB Securities Buy $7.50
06-Apr-10Downgrade Brean Murray Buy → Hold
13-Feb-09Upgrade SMH Capital Neutral → Accumulate $31 → $27
09-Jul-08Initiated Brean Murray Buy $5
21-Oct-14 06:00AM  Sinovac to Participate in Jefferies 4th Annual Asia Summit PR Newswire
08-Oct-14 08:30AM  3 Biotech Stocks Under $10 in Breakout Territory at TheStreet +7.57%
05-Sep-14 06:00AM  Sinovac Announces New Presentation Time for Aegis Healthcare & Technology Conference PR Newswire
02-Sep-14 06:00AM  Sinovac to Participate in Upcoming Investor Conferences PR Newswire -9.22%
27-Aug-14 06:00AM  Sinovac Announces Results of 2014 Annual General Meeting of Shareholders PR Newswire
14-Aug-14 12:49PM  Sinovac Reports Unaudited Second Quarter Financial Results PR Newswire
25-Jul-14 05:00AM  Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results PR Newswire
23-Jul-14 06:00AM  Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu PR Newswire
21-Jul-14 09:08AM  Mondays Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech at Motley Fool
06:09AM  Sinovac Biotech receives tender to supply Healive in Beijing under EPI at theflyonthewall.com
06:00AM  Sinovac Receives Tender to Supply Inactivated Hepatitis A Vaccine Healive in Beijing Under Expanded Immunization Program PR Newswire
14-Jul-14 06:00AM  Sinovac Schedules 2014 Annual Meeting of Shareholders PR Newswire
25-Jun-14 06:00AM  Sinovac Announces Favorable Reduction in Value Added Tax Rate PR Newswire
22-May-14 11:39AM  Sinovac Biotech's (SVA) CEO Weidong Yin on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
21-May-14 06:01PM  Sinovac Biotech reports Q1 EPS 0c, consensus (3c) at theflyonthewall.com
06:00PM  Sinovac Reports Unaudited First Quarter 2014 Financial Results PR Newswire
12-May-14 06:00AM  Sinovac to Host Conference Call to Report First Quarter 2014 Unaudited Financial Results PR Newswire
28-Apr-14 06:38AM  Sinovac Biotech enters technology transfer agreement with Intravacc at theflyonthewall.com
06:09AM  Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV) PR Newswire
24-Apr-14 06:00AM  Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project PR Newswire
22-Apr-14 01:04PM  SINOVAC BIOTECH LTD Financials EDGAR Online Financials
16-Apr-14 09:15AM  Sinovac Files 2013 Annual Report on Form 20-F PR Newswire
21-Mar-14 06:03AM  Sinovac Biotech (SVA) Soars: Stock Rises 17.1% Zacks -6.69%
20-Mar-14 05:16PM  Why Sinovac Biotech, Burlington Stores, and ZIOPHARM Oncology Are Today's 3 Best Stocks at Motley Fool +17.13%
12:57PM  Sinovac Biotech's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
12:17PM  On The Fly: Midday Wrap at theflyonthewall.com
19-Mar-14 06:00PM  Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results PR Newswire
07:07AM  Q4 2013 SINOVAC BIOTECH LTD Earnings Release - After Market Close CCBN
17-Mar-14 04:36PM  Sinovac Biotech Is The One Chinese Company That Should Be In Your Portfolio at Seeking Alpha
12-Mar-14 06:00AM  Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2013 Unaudited Financial Results PR Newswire
26-Feb-14 05:01PM  Sinovac's EV71 Vaccine Phase III Clinical Trial Results Published in New England Journal of Medicine PR Newswire
29-Jan-14 07:14AM  Sinovac Biotech files clinical trial application in China for Avian Influenza theflyonthewall.com
07:07AM  Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine against Avian Influenza A(H7N9) Virus PR Newswire
21-Nov-13 04:07PM  Negotiators Adjourn Talks on Farm Bill Until After Recess Optionetics
13-Nov-13 01:51PM  Sinovac Biotech's CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha +5.60%
12-Nov-13 06:00PM  Sinovac Reports Unaudited Third Quarter 2013 Financial Results PR Newswire
07:07AM  Q3 2013 SINOVAC BIOTECH LTD Earnings Release - After Market Close CCBN
07-Nov-13 07:05AM  InPlay: Sinovac Biotech receives Jiangsu Province tender award to supply inactivated hepatitis vaccine Healive under expanded immunization program Briefing.com
07:00AM  Sinovac Receives Jiangsu Province Tender Award to Supply Inactivated Hepatitis Vaccine Healive(R) under Expanded Immunization Program PR Newswire
04-Nov-13 07:00AM  Sinovac to Host Conference Call to Report Third Quarter 2013 Unaudited Financial Results PR Newswire +5.30%
31-Oct-13 07:00AM  Sinovac to Participate in UBS Asia Healthcare CEO Summit in November 2013 PR Newswire
28-Aug-13 09:00AM  CCG Investor Relations and MarcumBP Announces Final Line-up for China Best Ideas Investment Conference, September 10th in Beijing PR Newswire
21-Aug-13 08:00AM  Sinovac Holds 2013 Annual General Meeting of Shareholders PR Newswire
15-Aug-13 02:23AM  Sinovac Biotech upgraded by Aegis Capital Briefing.com
14-Aug-13 02:32PM  Why Sinovac Biotech Ltd. Shares Spiked Higher at Motley Fool +6.78%
11:43AM  Sinovac's CEO Discusses Q2 2013 Results - Earnings Call Transcript at Seeking Alpha
09:05AM  Futures Tick Lower, John Paulson Makes Steinway Bid, Millennial Media Plunges 28% at Barrons.com
13-Aug-13 09:41PM  Sinovac Reports Unaudited Second Quarter 2013 Financial Results PR Newswire
07:07AM  Q2 2013 SINOVAC BIOTECH LTD Earnings Release - After Market Close CCBN
11-Aug-13 08:13PM  Sinovac Biotech Earnings: What Investors Should Watch at Wall St. Cheat Sheet
31-Jul-13 08:00AM  Sinovac to Host Conference Call to Report Second Quarter 2013 Unaudited Financial Results PR Newswire
19-Jul-13 08:00AM  Sinovac Schedules 2013 Annual Meeting of Shareholders PR Newswire
02-Jun-13 02:55AM  China Biotech In Review: Valeant Pharma Gains Sales Foothold In China With Bausch & Lomb Buy at Seeking Alpha
31-May-13 04:05PM  Sinovac Appoints New Chief Financial Officer PR Newswire
30-May-13 05:00AM  Sinovac Files New Drug Application for EV71 Vaccine and Receives Filing Acceptance from Beijing Drug Administration PR Newswire
28-May-13 06:30PM  Deadly Strain of Hand, Foot and Mouth Disease Blocked in Study at Bloomberg +20.54%
04:20PM  Sinovac climbs on 1Q hepatitis A vaccine sales AP
02:41PM  Sinovac Biotech's CEO Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
07:10AM  Sinovac Reports Unaudited First Quarter 2013 Financial Results PR Newswire
07:07AM  Q1 2013 SINOVAC BIOTECH LTD Earnings Release - Before Market Open CCBN
26-May-13 04:04AM  Sinovac Biotech Earnings: What Investors Should Watch at Wall St. Cheat Sheet
24-May-13 05:00AM  Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines PR Newswire
17-May-13 05:11AM  Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results PR Newswire
15-May-13 06:15AM  Sinovac Biotech appoints Ernst & Young Hua Ming China as external auditor theflyonthewall.com
06:07AM  Sinovac Appoints Ernst & Young Hua Ming Llp China as External Auditor PR Newswire
14-May-13 06:00AM  Sinovac Presents at the UBS Global Healthcare Conference in May 2013 PR Newswire
01-May-13 09:09AM  Scientists Infect Chicks in Race to Halt Bird Flu Spread at Bloomberg -5.06%
30-Apr-13 07:48AM  Sinovac Files Annual Report on Form 20-F PR Newswire
18-Apr-13 04:14PM  Sinovac posts 4Q loss as expenses rise AP -9.93%
01:45PM  Why Sinovac Is Poised to Keep Pulling Back at Motley Fool
01:00PM  Sinovac Biotech's CEO Discusses F4Q2012 Results - Earnings Call Transcript at Seeking Alpha
08:02AM  Sinovac Reports Unaudited Fourth Quarter and Full Year 2012 Financial Results PR Newswire
07:17AM  Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo PR Newswire
07:07AM  Q4 2012 SINOVAC BIOTECH LTD Earnings Release - Before Market Open CCBN
07:05AM  Sinovac Receives Commercial Approval in Mexico for Seasonal Flu Vaccine PR Newswire
Sinovac Biotech Ltd., a biopharmaceutical company, is engaged in the research, development, manufacture, and commercialization of vaccines for hepatitis A, hepatitis B, and influenza viruses in the People's Republic of China. Its marketed products include Healive, an inactivated hepatitis A vaccine; Bilive, a combined inactivated hepatitis A and B vaccine; Anflu, a split viron influenza vaccine; Panflu, a vaccine against the H5N1 influenza virus; Panflu.1, a vaccine against the influenza A H1N1 virus; mumps vaccine; split viron pandemic influenza vaccine; and RabEnd, an animal rabies vaccine. The company has also completed a phase I clinical trial of a SARS vaccine, as well as develops the EV71 vaccine, which has completed phase III clinical trial. Further, it develops a pipeline of vaccine candidates in the clinical and pre-clinical development phases, including human vaccines for pneumococcal, rabies, varicella, and rubella that are in pre-clinical stage. The company has a collaboration agreement with Tianjin CanSino Biotechnology Inc. to develop a pneumococcal vaccine; and a license agreement with Medimmune, LLC to use patented reverse genetics technology pertaining to virus strain production for vaccines, including the H5N1 influenza virus strain. Sinovac Biotech Ltd. was founded in 1999 and is headquartered in Beijing, the People's Republic of China.